Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens83.3% of ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA ...

March is the awareness month for colorectal cancer and multiple myeloma. If you’re interested in speaking to experts, contact media@fredhutch.org to schedule interviews. Scientists develop ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA there were likely a small number of children killed by ...

A misdiagnosed emergency nurse’s severe headaches reveal key signs and symptoms of a cluster headache and the importance of ...

After a median follow-up of 13.3 months (95% CI, 9.04-18.69), the median duration of response was 18.1 months, progression ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. This randomised, open-label, phase 2 study was conducted at 34 clinical sites across Australia, Canada ...

Biologic drugs have improved how doctors treat serious illnesses. Instead of being made from chemicals, biologics are made from organic materials and grown in living cells. Biologic drugs are used ...

Detailed immune profiling in long-term care populations reveals that SARS-CoV-2 vaccines and infections drive powerful virus-specific responses while leaving lifelong common cold immunity largely ...